Dexmedetomidine, sold under the trade names Precedex among others, is an
anxiety reducing, sedative, and pain medication. Dexmedetomidine is notable for
Medscape - Indication-specific dosing for Precedex, (dexmedetomidine),
frequency-based adverse effects, comprehensive interactions, contraindications,
Dexmedetomidine was approved by the Food and Drug Administration at the end
of 1999 for use in humans as a short-term medication (<24 hours) for ...
Dexmedetomidine Hydrochloride Injection official prescribing information for
healthcare professionals. Includes: indications, dosage, adverse reactions, ...
Effect of sedation with dexmedetomidine vs lorazepam on acute brain
dysfunction in mechanically ventilated patients: the MENDS randomized
Dexmedetomidine. Dex was developed in the 1990s by Orion and Abbott as a
sedative for use in the intensive care unit setting. In 1999, Abbott received FDA ...
This group includes drugs, which cannot be classified in the preceding groups.
ATC code, Name, DDD, U, Adm.R, Note. N05CM18, dexmedetomidine, 1, mg, P
This randomized clinical trial assesses the effectiveness of dexmedetomidine
when added to standard care in patients with agitated delirium receiving ...
Dexmedetomidine: A Useful Adjunct to Consider in Some High-Risk Situations.
Mariann A. Haselman, CRNA, MSNA. Dexmedetomidine (DEX) is a selective a2
Sep 26, 2015 ... Dexmedetomidine is a relatively new drug to the UK having been launched in
October 2011 with marketing authorization for sedation of adult ...